Charge Injection Technologies, Inc. v. E.I. DuPont De Nemours & Company

CourtSuperior Court of Delaware
DecidedMarch 9, 2016
DocketN07C-12-134 JRJ
StatusPublished

This text of Charge Injection Technologies, Inc. v. E.I. DuPont De Nemours & Company (Charge Injection Technologies, Inc. v. E.I. DuPont De Nemours & Company) is published on Counsel Stack Legal Research, covering Superior Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Charge Injection Technologies, Inc. v. E.I. DuPont De Nemours & Company, (Del. Ct. App. 2016).

Opinion

IN THE SUPERIOR COURT OF THE STATE OF DELAWARE

CHARGE INJECTION ) TECHNOLOGIES, INC., ) ) Plaintiff, ) ) v. ) C.A. No. N07C-12-134-JRJ ) E.I. DUPONT DE NEMOURS & ) COMPANY, ) ) Defendant. )

OPINION

Date Submitted: December 11, 2015 Date Decided: March 9, 2016

Upon Defendant E. I. DuPont De Nemours & Company’s Motion to Dismiss: DENIED.

Arthur G. Connolly, III, Esquire, Ryan P. Newell, Esquire, Josiah R. Wolcott, Esquire, Connolly Gallagher LLP, The Brandywine Building, 1000 West Street, Suite 1400, Wilmington, DE 19801, Amir H. Alavi, Esquire (pro hac vice) (argued), Timothy C. Shelby, Esquire (pro hac vice), Lauren R. Reeder, Esquire (pro hac vice), Ahmad, Zavitsanos, Anaipakos, Alavi & Mensing P.C., 1221 McKinney, Suite 3460, Houston, TX 77010, Attorneys for Plaintiff Charge Injection Technologies, Inc.

Kathleen F. McDonough, Esquire (argued), John A. Sensing, Esquire, Michael B. Rush, Esquire, Potter Anderson & Corroon LLP, 1313 North Market Street, P.O. Box 951, Wilmington, DE 19801, Attorneys for Defendant E. I. du Pont de Nemours & Company.

Jurden, P.J. I. INTRODUCTION

Before the Court is Defendant E.I. Du Pont De Nemours and

Company’s (“DuPont”) Motion to Dismiss. 1 In 2007, Charge Injection

Technologies, Inc. (“CIT”) instituted this suit against DuPont, alleging that DuPont

wrongfully used and disclosed CIT’s proprietary and confidential technology.

Several years into the litigation, CIT entered into a financing agreement. DuPont

alleges that the financing agreement violates Delaware’s prohibition against

champerty and maintenance, and therefore, CIT’s claims against DuPont must be

dismissed. For the reasons set forth below, DuPont’s Motion to Dismiss based on

champerty and maintenance is DENIED.

II. BACKGROUND

CIT filed suit against DuPont in December 2007, alleging that DuPont

wrongfully used and disclosed CIT’s proprietary and confidential technology. 2

Lacking adequate resources to pursue what became costly and protracted litigation,

Ross James (“James”), CIT’s Chief Executive Officer, sought third-party financing

in 2008 to help cover the costs of this litigation as well as other business expenses. 3

CIT entered into two separate agreements—one with Latigo IP, LLC

1 Defendant E.I. Du Pont De Nemours and Company’s Opening Brief in Support of its Motion to Dismiss (“Def.’s Mot. Dismiss”) (Trans. ID. 57739103). 2 Third Am. Compl. ¶ 1 (Trans. ID. 29596891). 3 Plaintiff Charge Injection Technologies, Inc.’s Brief in Opposition to Defendant DuPont’s Motion to Dismiss at 3 (“Pl.’s Opp’n”) (Trans. ID. 57854661); Def.’s Mot. Dismiss, Ex. A Declaration of Ross James ¶¶ 2–3 (“James Decl.”). Ross James has been the Chief Executive Officer of CIT since 2000. James Decl. ¶ 1.

2 (“Latigo”) and one with Fortitude Advisors (“Fortitude”)—pursuant to which

Latigo and Fortitude would assist CIT with securing third-party financing. 4 Frank

Knuettel (“Knuettel”) is CIT’s primary contact with Latigo, and Chris Wilson

(“Wilson”) is CIT’s primary contact with Fortitude.5

In 2010, Wilson contacted Burford Capital LLC, 6 an investment advisor that

conducts due diligence for Burford Capital Ltd., a United Kingdom company that

provides litigation financing (“Burford”). 7 Wilson spoke with Aviva Will

(“Will”), the Managing Director at Burford. 8 After providing Burford with non-

confidential information about the litigation, CIT and Burford entered into a non-

disclosure agreement. 9 Although Burford and CIT had preliminary discussions

about potential financing in 2010, no formal negotiations took place at that time

because Burford decided not to fund the litigation.10

On October 31, 2011, CIT’s original counsel withdrew. 11 While CIT was

searching for new counsel, Wilson contacted Will again to see if Burford might

4 James Decl. ¶¶ 20–21, 25–28. In exchange for their services, Latigo and Fortitude would earn fees upon a third-party’s financing of this litigation. Id. 5 Id. 6 Burford Capital LLC was then known as Burford Group LCC. Def.’s Mot. Dismiss, Ex. C Deposition of Aviva Will at 21–22 (“Will Dep.”). 7 Id. at 21–22, 27–28; Def.’s Mot. Dismiss, Ex. B Deposition of Ross James at 49–52 (“Def.’s Ex. B James Dep.”). This Opinion will refer to both entities as “Burford.” 8 Def.’s Ex. B James Dep. at 49–52; Will Dep. at 28–29. As Managing Director at Burford Capital LLC, Will is responsible for underwriting and monitoring investments. Will Dep. at 20– 21. 9 Will Dep. at 30–37. 10 Id. at 47–49. 11 See Trans. ID. 40632788.

3 reconsider its financing decision. 12 At that time, Burford’s “portfolio was larger

and more diverse,” and Burford was willing to take “a more substantive look” at

the case. 13 Burford spent several months conducting due diligence, which included

discussions with CIT’s potential new counsel, Ahmad, Zavitsanos, Anaipakos,

Alavi & Mensing (“AZA”), and with CIT regarding the potential financing

terms. 14 On December 1, 2011, CIT’s current lead counsel, AZA entered its

appearance in the case. 15

Following negotiations between CIT and Burford, a financing agreement

was finalized on June 15, 2012, subject to approval from CIT’s Board of Directors

and Burford’s Board of Directors. 16 CIT’s Board of Directors and Burford’s Board

of Directors approved the deal, and CIT entered into the “Forward Purchase

Agreement” (“FPA”) with Aloe Investments Limited (“Aloe”), a subsidiary of

Burford. 17 Pursuant to the FPA, Aloe provided financing in exchange for a

percentage of any future proceeds of the litigation and obtained a security interest

in CIT’s claim as collateral.18

12 Will Dep. at 49, 53–55. 13 Id. at 80–82. 14 Id. at 55–61, 82. Will initially spoke with Wilson but also spoke with James and Gary Benton, CIT’s outside legal advisor. Id. at 59–63. 15 See Trans. ID. 41184823; Trans. ID. 41143308; Trans. ID. 52178115. 16 Will Dep. at 68–71. 17 Id. at 24–26, 88–101; Def.’s Mot. Dismiss, Ex. D, E. 18 Def.’s Mot. Dismiss Ex. G Forward Purchase Agreement. AZA is representing CIT on a contingency basis. Pl.’s Opp’n at 6.

4 III. STANDARD OF REVIEW

The common law doctrines of champerty and maintenance originated in

Medieval England in response to the practice of feudal lords and other wealthy

individuals financing other individuals’ legal claims, usually against the financier’s

political or personal enemies, in exchange for a share of the results.19 These

“champertors” enlisted paid retainers—known as “maintainers”—who would

prosecute the suits ruthlessly on the champertors’ behalf.20 Such claims often

involved title to land, which meant that the champertor would grow richer by

becoming a joint owner of the landed estate. 21

“Because kings soon found themselves the target of this vexatious litigation,

and because of a [ ] distaste for litigation in general, laws against champerty and

maintenance were born.”22 The historical justification for prohibiting any form of

champerty or maintenance was to prevent disinterested third-parties from stirring

19 Osprey, Inc. v. Cabana Ltd. P’ship, 532 S.E.2d 269, 374–75 (2000); Andrew Hananel & David Staubitz, The Ethics of Law Loans in the Post-Rancman Era, 17 GEO. J. LEGAL ETHICS 795, 797–98 (2004); Ronald C. Minkoff & Andrew D. Patrick, Taming the Champerty Beast: A Proposal for Funding Class Action Plaintiffs, 15 PROF. LAW. 1, Spring 2004 at 1.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Osprey, Inc. v. Cabana Ltd. Partnership
532 S.E.2d 269 (Supreme Court of South Carolina, 2000)
Hall v. State
655 A.2d 827 (Superior Court of Delaware, 1994)
Bayard v. McLane
3 Del. 139 (Supreme Court of Delaware, 1840)
Gibson v. Gillespie
152 A. 589 (Superior Court of Delaware, 1928)
Hannigan v. Italo Petroleum Corp. of America
178 A. 589 (Superior Court of Delaware, 1935)

Cite This Page — Counsel Stack

Bluebook (online)
Charge Injection Technologies, Inc. v. E.I. DuPont De Nemours & Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/charge-injection-technologies-inc-v-ei-dupont-de-nemours-company-delsuperct-2016.